Advertisement

Dermatology pp 279-303 | Cite as

Pharmacology and Drug Reactions

  • Sima Jain
Chapter

Abstract

Binds and inactivates bacterial enzymes (PCN-binding proteins) involved in peptidoglycan synthesis → inhibits bacterial cell wall synthesis

Keywords

Toxic Epidermal Necrolysis Pyoderma Gangrenosum Porphyria Cutanea Tarda Acute Generalize Exanthematous Pustulosis Pregnancy Category 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Adams DR. Adverse drug reactions in the skin. In: Schwarzenberger K, Werchniak AE, Ko CJ, eds.Requisites in Dermatology: General Dermatology. Philadelphia, PA: Elsevier Ltd; 2009:365-388.CrossRefGoogle Scholar
  2. 2.
    Akamatsu H, Zouboulis CC, Orfanos CE. Spironolactone directly inhibits proliferation of cultured human facial sebocytes and acts antagonistically to testosterone and 5-dihydrotestosterone in vitro.J Investig Dermatol. 1993;100:660-662.PubMedCrossRefGoogle Scholar
  3. 3.
    Armstrong AW. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. In: Schwarzenberger K, Werchniak AE, Ko CJ, eds.Requisites in Dermatology: General Dermatology. Philadelphia, PA: Elsevier Ltd; 2009:23-28.CrossRefGoogle Scholar
  4. 4.
    Badalementi S, Kerdel F. Azathioprine. In: Wolverton SE, ed.Comprehensive Dermatologic Drug Therapy. Philadelphia, PA: W.B. Saunders Company; 2001:165-179.Google Scholar
  5. 5.
    Braiteh F, Kurzrock R. Trichomegaly of the eyelashes after lung cancer treatment with the epidermal growth factor receptor inhibitor erlotinib.J Clin Oncol. 2008;26(20):3460-3462.PubMedCrossRefGoogle Scholar
  6. 6.
    Burgin S, Wolverton SE, Callen JP. Cutaneous drug eruptions. In: Callen JP, Jorizzo JL, eds.Dermatological Signs of Internal Disease. 4th ed. Philadelphia, PA: Elsevier Ltd; 2009:401-410.CrossRefGoogle Scholar
  7. 7.
    Callen JP, Camisa C. Antimalarial agents. In: Wolverton SE, ed.Comprehensive Dermatologic Drug Therapy. Philadelphia, PA: W.B. Saunders Company; 2001:251-268.Google Scholar
  8. 8.
    Callen JP, Kulp-Shorten CL, Wolverton SE. Methotrexate. In: Wolverton SE, ed.Comprehensive Dermatologic Drug Therapy. Philadelphia, PA: W.B. Saunders Company; 2001:147-164.Google Scholar
  9. 9.
    Del Rosso JQ. Topical chemotherapy for the treatment of skin cancer. In: Rigel DS et al., eds.Cancer of the Skin. Philadelphia, PA: Elsevier Saunders Inc; 2005:619-630.Google Scholar
  10. 10.
    Evans TY, Vander Straten MR, Carrasco DA, Carlton S, Tyring SK. Systemic antiviral agents. In: Wolverton SE, ed.Comprehensive Dermatologic Drug Therapy. Philadelphia, PA: W.B. Saunders Company; 2001:85-108.Google Scholar
  11. 11.
    French LE, Prins C. Toxic epidermal necrolysis. In: Bolognia JL, Jorizzo JL, Rapini RP, eds.Dermatology. 2nd ed. St. Louis, MO: Mosby Elsevier; 2008:323-330.Google Scholar
  12. 12.
    Gollnick H. Systemic Therapy. In: Burgdorf WH, Plewig G, Wolff HH, Ladthaler M, eds.Braun-Falco’s Dermatology. 3rd ed. Heidelberg: Springer; 2009:1573-1593.CrossRefGoogle Scholar
  13. 13.
    Gordon KB, West DP. Biologic therapy in dermatology. In: Wolverton SE, ed.Comprehensive Dermatologic Drug Therapy. Philadelphia, PA: W.B. Saunders Company; 2001:928-942.Google Scholar
  14. 14.
    Greaves MW. Antihistamines. In: Wolverton SE, ed.Comprehensive Dermatologic Drug Therapy. Philadelphia, PA: W.B. Saunders Company; 2001:360-374.Google Scholar
  15. 15.
    Gupta AK. Systemic antifungal agents. In: Wolverton SE, ed.Comprehensive Dermatologic Drug Therapy. Philadelphia, PA: W.B. Saunders Company; 2001:55-84.Google Scholar
  16. 16.
    Holzle E. Physical therapy: light, cold, heat. In: Burgdorf WH, Plewig G, Wolff HH, Ladthaler M, eds.Braun-Falco’s Dermatology. 3rd ed. Heidelberg: Springer; 2009:1593-1608.Google Scholar
  17. 17.
    Honigsmann H, Schwarz T. Ultraviolet light therapy. In: Bolognia JL, Jorizzo JL, Rapini RP, eds.Dermatology. 2nd ed. St. Louis, MO: Mosby Elsevier; 2008:2109-2119.Google Scholar
  18. 18.
    Knowles SR, Shear NH. Drug hypersensitivity syndromes. In: Wolverton SE, ed.Comprehensive Dermatologic Drug Therapy. Philadelphia, PA: W.B. Saunders Company; 2001:872-884.Google Scholar
  19. 19.
    Kuenzli S, Saurat JH. Retinoids. In: Bolognia JL, Jorizzo JL, Rapini RP, eds.Dermatology. 2nd ed. St. Louis, MO: Mosby Elsevier; 2008:1991-2006.Google Scholar
  20. 20.
    Kufe DW, Pollock RE, Weichselbaum RR, et al.Holland-Frei Cancer Medicine. 6th ed. Hamilton, ON: BC Decker Inc; 2003.Google Scholar
  21. 21.
    Levy SB. Sunscreens. In: Wolverton SE, ed.Comprehensive Dermatologic Drug Therapy. Philadelphia, PA: W.B. Saunders Company; 2001:632-646.Google Scholar
  22. 22.
    Lipp HP, ed.Anticancer Drug Toxicity: Prevention, Management, and Clinical Pharmacokinetics. New York, NY: Marcel Dekker Inc; 1999:263-270.Google Scholar
  23. 23.
    Malvasi A, Tinelli A, Buia A, DeLuca GF. Possible long-term teratogenic effect of isotretinoin in pregnancy.Eur Rev Med Pharmacol Sci. 2009;13:393-396.PubMedGoogle Scholar
  24. 24.
    Mockenhaupt M. Severe cutaneous adverse reactions. In: Burgdorf WH, Plewig G, Wolff HH, Ladthaler M, eds.Braun-Falco’s Dermatology. 3rd ed. Heidelberg: Springer; 2009:473-484.CrossRefGoogle Scholar
  25. 25.
    Nesbitt LT. Glucocorticoids. In: Bolognia JL, Jorizzo JL, Rapini RP, eds.Dermatology. 2nd ed. St. Louis, MO: Mosby Elsevier; 2008:1979-1986.Google Scholar
  26. 26.
    Nguyen EQ, Wolverton SE. Systemic retinoids. In: Wolverton SE, ed.Comprehensive Dermatologic Drug Therapy. Philadelphia, PA: W.B. Saunders Company; 2001:269-310.Google Scholar
  27. 27.
    Perry MC.The Chemotherapy Source Book. 4th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2008:148-152.Google Scholar
  28. 28.
    Reed BR. Dermatologic drugs during pregnancy and lactation. In: Wolverton SE, ed.Comprehensive Dermatologic Drug Therapy. Philadelphia, PA: W.B. Saunders Company; 2001:817-847.Google Scholar
  29. 29.
    Revus J, Valeyrie-Allanore L. Drug reactions. In: Bolognia JL, Jorizzo JL, Rapini RP, eds.Dermatology. 2nd ed. St. Louis, MO: Mosby Elsevier; 2008:333-351.Google Scholar
  30. 30.
    Sadick N. Systemic antibacterial agents. In: Wolverton SE, ed.Comprehensive Dermatologic Drug Therapy. Philadelphia, PA: W.B. Saunders Company; 2001:28-54.Google Scholar
  31. 31.
    Shapiro LE, Knowles SR, Shear N. Drug-drug interactions. In: Bolognia JL, Jorizzo JL, Rapini RP, eds.Dermatology. 2nd ed. St. Louis, MO: Mosby Elsevier; 2008:2085-2110.Google Scholar
  32. 32.
    Shapiro LE, Shear NH. Drug interactions. In: Wolverton SE, ed.Comprehensive Dermatologic Drug Therapy. Philadelphia, PA: W.B. Saunders Company; 2001:848-871.Google Scholar
  33. 33.
    Teitelbaum JE, Perez-Atayde AR, Cohen M, Bousvaros A, Jonas MM. Minocycline-related autoimmune hepatitis.Arch Pediatr Adolesc Med. 1998;152:1132-1136.PubMedGoogle Scholar
  34. 34.
    Tope WD, Shaffer JJ. Photodynamic therapy. In: Bolognia JL, Jorizzo JL, Rapini RP, eds.Dermatology. 2nd ed. St. Louis, MO: Mosby Elsevier; 2008:2127-2140.Google Scholar
  35. 35.
    Wolverton SE, Callen JP. Cutaneous drug eruptions. In: Callen JP, Jorizzo JL, Bolognia JL, Piette WW, Zone JJ, eds.Dermatological Signs of Internal Disease. 3rd ed. Philadelphia, PA: Elsevier Science Ltd; 2003:343-351.Google Scholar
  36. 36.
    Wolverton SE, Callen JP. Systemic therapy for cutaneous disease. In: Callen JP, Jorizzo JL, eds.Dermatological Signs of Internal Disease. 4th ed. Philadelphia, PA: Elsevier Inc; 2009:411-414.CrossRefGoogle Scholar
  37. 37.
    Wolverton SE. Systemic Corticosteroids. In: Wolverton SE, ed.Comprehensive Dermatologic Drug Therapy. Philadelphia, PA: W.B. Saunders Company; 2001:109-148.Google Scholar
  38. 38.
    Woody CM, Lesher JL. Antimicrobial drugs. In: Bolognia JL, Jorizzo JL, Rapini RP, eds.Dermatology. 2nd ed. St. Louis, MO: Mosby Elsevier; 2008:2007-2032.Google Scholar
  39. 39.
    Zelickson BD. Mechanism of action of topical aminolevulinic acid. In: Goldman MP, ed.Photodynamic Therapy. 2nd ed. Philadelphia, PA: Saunders Elsevier; 2008:1-9.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Sima Jain
    • 1
    • 2
  1. 1.College of Medicine Private PracticeAssistant Clinical Professor of Dermatology University of Illinois at ChicagoWest DundeeUSA
  2. 2.OrlandoUSA

Personalised recommendations